Bart Landuyt - Co-Founder, CellSine
Short description of the presentation:
A disruptive novel technology has been established by the universities of Brussels and Leuven to enable label-free, high-throughput drug discovery.
Bart Landuyt obtained a master degree in bio-engineering (KU Leuven), a PhD in medical sciences – Oncology (KU Leuven), and an MBA (Vlerick business school). Bart works as a business development manager for the KU Leuven industrial research fund. Bart is founder of two biotech companies: DKR brewery (2010) and CellSine (2015).